[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
February 26, 1938


JAMA. 1938;110(9):675-676. doi:10.1001/jama.1938.02790090057023

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  The communication of the Scarlet Fever Committee published in the Nov. 27, 1937, issue of The Journal should not go unanswered. Any criticism must be directed at the manner in which the Dick patent has been handled by the Scarlet Fever Committee. The communication of the Scarlet Fever Committee draws a comparison between the 5 per cent royalty fixed for the Dick patent and the royalty of 10 per cent fixed by the Insulin Committee. These two patents were taken out under different circumstances in relation to the groundwork covered by previous investigators. The ten points of the Dick patent embrace a much wider field in scarlet fever than the insulin patent in diabetes. The Dick patent covers: (1) not only the original strain of scarlet fever producing hemolytic streptococcus but all subsequent strains discovered and yet to be discovered before the patent runs out; (2) the

First Page Preview View Large
First page PDF preview
First page PDF preview